Metasphere Labs Inc.
LABZ
CNSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.84% | -31,109.52% | -405.11% | -130.74% | 91.63% |
| Total Depreciation and Amortization | -- | -- | -147.79% | -26.36% | -86.27% |
| Total Amortization of Deferred Charges | -- | -- | -55.21% | -55.21% | -55.21% |
| Total Other Non-Cash Items | -41.24% | -60.22% | -27.54% | -39.14% | -92.06% |
| Change in Net Operating Assets | 80.90% | 69.05% | 62.11% | -9.12% | -844.23% |
| Cash from Operations | 52.76% | -18.59% | -99.57% | -356.21% | -54.85% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -101.75% |
| Total Debt Repaid | 100.00% | 50.88% | -4,614.81% | -357.96% | -412.63% |
| Issuance of Common Stock | -98.63% | -77.54% | 34.45% | 47.93% | 533.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.52% | -80.22% | 33.63% | 27.12% | 84.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -202.60% | -195.73% | -164.26% | -163.85% | 648.67% |